2024    2023    2022    2021    2020    2019    2018    2017    2016   

2016

Articles

161 - 

Atrial Fibrillation in a Dual-Chamber ICD Recipient with Activation of the Ventricular Intrinsic Preference Algorithm: What Is the Mechanism?

R.P. Martins, V. Galand, N. Behar, P. Mabo, J.-C. Daubert et al.

PACE - Pacing and Clinical Electrophysiology, 2016, 39 (8), pp.880--882.

DOI : https://doi.org/10.1111/pace.12900

Pubmed : 27230533

 

162 - 

CLOSE: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design

Jean-Louis Mas, Geneviève Derumeaux, Pierre Amarenco, Caroline Arquizan, Pierre Aubry et al.

International Journal of Stroke, 2016, 11 (6), pp.724--732.

DOI : https://doi.org/10.1177/1747493016643551

Pubmed : 27056964

 

163 - 

Does Deep Bradycardia Increase the Risk of Arrhythmias and Syncope in Endurance Athletes?

D. Matelot, Frédéric Schnell, N. Khodor, N. Endjah, G. Kervio et al.

International Journal of Sports Medicine, 2016, 37 (10), pp.792--798.

DOI : https://doi.org/10.1055/s-0035-1569348

Pubmed : 27286180

 

164 - 

Re: Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis from the National Cancer Data Base

Romain Mathieu, Benoit Peyronnet, Karim Bensalah

European Urology, 2016, 70 (5), pp.894--894.

DOI : https://doi.org/10.1016/j.eururo.2016.07.048

Pubmed : 27497763

 

165 - 

Frey procedure combined with biliary diversion in chronic pancreatitis

Aude Merdrignac, Damien Bergeat, Michel Rayar, Yann Harnoy, Kathleen Turner et al.

Surgery, 2016, 160 (5), pp.1264--1270.

DOI : https://doi.org/10.1016/j.surg.2016.05.006

Pubmed : 27320066

 

166 - 

Endocardite tricuspide à Cardiobacterium hominis illustrant le paradoxe de la pauvreté des signes cliniques malgré une atteinte valvulaire sévère[A case of tricuspid valve endocarditis due to Cardiobacterium hominis which emphasizes the shift between the poverty of clinical symptoms and the severity of cardiac damages]

Lucie Molet, Matthieu Revest, Maxime Fournet, Erwan Donal, Martine Bonnaure-Mallet et al.

Annales de Biologie Clinique, 2016, 74 (6), pp.693--696.

DOI : https://doi.org/10.1684/abc.2016.1187

Pubmed : 27707668

 

167 - 

Impact of bevacizumab-based chemotherapy on outcomes of liver resections in colorectal metastases: Results from a propensity matched analysis

Y. Mouchel, L. Sulpice, D. Bergeat, M. Rayar, C. Pery et al.

HPB, 2016, Abstracts of the 11th International Congress of the European-African Hepato-Pancreato-Biliary Association, 21-24 April 2015, Manchester, UK, 18, Supplement 2, pp.e698.

DOI : https://doi.org/10.1016/j.hpb.2016.01.098

 

168 - 

The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock

Grégoire Muller, Erwan Flécher, Guillaume Lebreton, Charles-Edouard Luyt, Jean-Louis Trouillet et al.

Intensive Care Medicine, 2016, 42 (3), pp.370-8.

DOI : https://doi.org/10.1007/s00134-016-4223-9

Pubmed : 26825953

 

169 - 

Effectiveness and complications of ultrasound-guided subclavian vein cannulation in children and neonates

Nicolas Nardi, Eric Wodey, Bruno Laviolle, François de La Brière, Séverine Delahaye et al.

Anaesthesia Critical Care & Pain Medicine, 2016, 35 (3), pp.209-213.

DOI : https://doi.org/10.1016/j.accpm.2015.09.007

Pubmed : 26924612

 

170 - 

Evaluation in alcohol use disorders - insights from the nalmefene experience

Florian Naudet, C. Palpacuer, R. Boussageon, B. Laviolle

BMC Medicine, 2016, 14 (1), pp.119.

DOI : https://doi.org/10.1186/s12916-016-0664-9

Pubmed : 27534932